Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/SLS

    SELLAS Life Sciences Group, Inc.(SLS)

    Biotechnology
    Oncology Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    50.0
    Insider Trading Score
    Peer Group Scores
    PRLD
    87
    CRIS
    75
    CRVS
    65
    RLAY
    58
    CGEM
    56
    SLS
    50
    BYSI
    50
    LIANY
    50
    SGMO
    36
    TNGX
    33
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2025-11-21
    Kalin Katherine Bach
    Director
    Purchase
    +63,400
    +154.63%104,400
    $1.59$100,806View SEC filing
    2025-06-13
    VAN NOSTRAND ROBERT L
    Director
    Purchase
    +10,000
    +96.15%20,400
    $1.48$14,800View SEC filing
    2025-06-02
    Wasman Jane
    Director
    Purchase
    +20,000
    +192.31%30,400
    $1.69$33,800View SEC filing
    2025-05-22
    Kalin Katherine Bach
    Director
    Purchase
    +20,000
    +95.24%41,000
    $1.80$36,000View SEC filing
    2022-12-05
    Stergiou Angelos M.
    President and CEO
    Sale
    -6,494
    -3.86%161,689
    $2.61$16,938View SEC filing
    2022-12-05
    Burns John Thomas
    Senior VP, Finance & CAO
    Sale
    -1,159
    -3.80%29,347
    $2.59$3,002View SEC filing
    2022-12-05
    WOOD BARBARA A
    EVP, Gen. Counsel, Corp. Sec.
    Sale
    -2,153
    -3.68%56,344
    $2.59$5,576View SEC filing
    2021-12-03
    Stergiou Angelos M.
    President and CEO
    Sale
    -2,120
    -1.72%121,167
    $6.25$13,252View SEC filing
    2021-12-03
    WOOD BARBARA A
    EVP, Gen. Counsel, Corp. Sec.
    Sale
    -847
    -1.98%42,028
    $6.25$5,298View SEC filing
    2021-12-03
    Burns John Thomas
    VP, Finance & Corp Controller
    Sale
    -231
    -1.29%17,644
    $6.27$1,448View SEC filing
    2019-01-03
    Stergiou Angelos M.
    President and CEO
    Sale
    -23,277
    -5.17%426,858
    $1.25$29,189View SEC filing
    2017-06-22
    Nisi Rudolph
    Director
    Sale
    -500
    -3.25%14,864
    $0.55$273View SEC filing
    2017-02-10
    Hudson Bay Capital Management LP
    10% Owner
    Mixed
    -2,253,441
    -53.71%2,036,559
    $15.48$38,285,290View SEC filing
    2016-06-07
    Dunlap Ryan
    Former Chief Financial Officer
    Sale
    -126,875
    -87.15%18,702
    $2.18$276,588View SEC filing
    2014-04-09
    KRIEGSMAN STEVEN A
    Director
    Sale
    -150,000
    -96.77%5,000
    $5.92$888,540View SEC filing
    2014-02-13
    Nisi Rudolph
    Director
    Purchase
    +20,000
    +571.43%23,500
    $4.94$98,742View SEC filing
    2014-02-13
    Chin Richard
    Director
    Sale
    -187,500
    -100.00%0
    $4.33$812,438View SEC filing
    2014-02-05
    GALLIKER STEPHEN S
    Director
    Sale
    -300,000
    -96.77%10,000
    $4.18$1,253,040View SEC filing
    2014-02-03
    Chin Richard
    Director
    Sale
    -75,000
    -100.00%0
    $5.58$418,755View SEC filing
    2014-01-31
    SCHWARTZ MARK W.
    EVP & Chief Operating Officer
    Sale
    -100,000
    -19.62%409,665
    $5.57$556,500View SEC filing
    2014-01-31
    Hillsberg Sanford
    Director
    Sale
    -250,000
    -93.29%17,974
    $5.41$1,352,500View SEC filing
    2014-01-31
    Nisi Rudolph
    Director
    Sale
    -250,000
    -98.62%3,500
    $5.28$1,320,000View SEC filing
    2014-01-29
    Ahn Mark J
    President & CEO
    Sale
    -796,765
    -87.51%113,764
    $4.83$3,848,375View SEC filing
    2014-01-22
    Hillsberg Sanford
    Director
    Sale
    -200,000
    -64.42%110,447
    $6.92$1,385,000View SEC filing
    2014-01-22
    KRIEGSMAN STEVEN A
    Director
    Sale
    -450,000
    -97.56%5,000
    $6.52$2,932,500View SEC filing

    1-25 of 80

    Page 1 of 4